Manager firm
Frostrow Capital LLP
Structure
investment_trust
AIC sector
Biotechnology & Healthcare
Domicile
United Kingdom
Base currency
GBP
Snapshot date
2025-08-31
Manager firm
Frostrow Capital LLP
Structure
investment_trust
AIC sector
Biotechnology & Healthcare
Domicile
United Kingdom
Base currency
GBP
Snapshot date
2025-08-31
Share price
1629.13p
NAV / share
—
Premium / discount
—
Fund size
—
OCF
—
Performance fee
—
Gearing
—
Dividend yield
—
| USA | 62.1% | |
| China | 21.4% | |
| Netherlands | 4.9% | |
| Denmark | 2.3% | |
| Far East & Pacific Region | 2.3% | |
| Germany | 2.2% | |
| Canada | 2.1% | |
| France | 2.0% | |
| Switzerland | 1.9% | |
| Cash near Cash | 1.0% |
| Portfolio yield | 0.44% |
| Unlisted holdings | — |
| Cash & equivalents | 1.01% |
| Total assets | £255.0m |
| Revenue reserves | £0 |
| Net gearing | 7.90% |
| Gross gearing | 9.00% |
| Net cash | £0 |
| Gearing range (from) | 0.00% |
| Gearing range (to) | 20.00% |
| Shares in issue | 23,845,881 |
| Shares issued | 0 |
| Shares purchased | 966,088 |
| Treasury shares | 0 |
Manager firm
Frostrow Capital LLP
Structure
investment_trust
AIC sector
Biotechnology & Healthcare
Domicile
United Kingdom
Base currency
GBP
Snapshot date
2025-08-31
Share price
1629.13p
NAV / share
—
Premium / discount
—
Fund size
—
OCF
—
Performance fee
—
Gearing
—
Dividend yield
—
| USA | 62.1% | |
| China | 21.4% | |
| Netherlands | 4.9% | |
| Denmark | 2.3% | |
| Far East & Pacific Region | 2.3% | |
| Germany | 2.2% | |
| Canada | 2.1% | |
| France | 2.0% | |
| Switzerland | 1.9% | |
| Cash near Cash | 1.0% |
| Portfolio yield | 0.44% |
| Unlisted holdings | — |
| Cash & equivalents | 1.01% |
| Total assets | £255.0m |
| Revenue reserves | £0 |
| Net gearing | 7.90% |
| Gross gearing | 9.00% |
| Net cash | £0 |
| Gearing range (from) | 0.00% |
| Gearing range (to) | 20.00% |
| Shares in issue | 23,845,881 |
| Shares issued | 0 |
| Shares purchased | 966,088 |
| Treasury shares | 0 |